Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

M S Bolhuis; O W Akkerman; M G G Sturkenboom; J F M van Boven; J-W C Alffenaar; J Stevens

doi:10.5588/ijtld.22.0581

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

M S Bolhuis, O W Akkerman, M G G Sturkenboom, J F M van Boven, J-W C Alffenaar, J Stevens

Onderzoeksoutput › Academic › peer review

Originele taal-2	English
Pagina's (van-tot)	335-337
Aantal pagina's	3
Tijdschrift	The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Volume	27
Nummer van het tijdschrift	4
DOI's	https://doi.org/10.5588/ijtld.22.0581
Status	Published - 1-apr.-2023

Toegang tot document

10.5588/ijtld.22.0581

Handle.net

Permanente koppeling

Citeer dit

Bolhuis, M. S., Akkerman, O. W., Sturkenboom, M. G. G., van Boven, J. F. M., Alffenaar, J.-W. C., & Stevens, J. (2023). Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 27(4), 335-337. https://doi.org/10.5588/ijtld.22.0581

@article{cadf0e1afbfd49d49bd43e4318688897,

title = "Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials",

keywords = "Humans, Antitubercular Agents/therapeutic use, Diarylquinolines/therapeutic use, Tuberculosis, Multidrug-Resistant/complications, Diabetes Complications/complications",

author = "Bolhuis, {M S} and Akkerman, {O W} and Sturkenboom, {M G G} and {van Boven}, {J F M} and Alffenaar, {J-W C} and J Stevens",

year = "2023",

month = apr,

day = "1",

doi = "10.5588/ijtld.22.0581",

language = "English",

volume = "27",

pages = "335--337",

journal = "The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union against Tubercul. and Lung Dis.",

number = "4",

}

Bolhuis, MS , Akkerman, OW , Sturkenboom, MGG , van Boven, JFM , Alffenaar, J-WC & Stevens, J 2023, 'Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials', The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 27, nr. 4, blz. 335-337. https://doi.org/10.5588/ijtld.22.0581

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials. / Bolhuis, M S ; Akkerman, O W ; Sturkenboom, M G G et al.
In: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Vol. 27, Nr. 4, 01.04.2023, blz. 335-337.

Onderzoeksoutput › Academic › peer review

TY - JOUR

T1 - Bedaquiline exposure in people with drug-resistant TB treated for diabetes

T2 - analysis of two phase 2 trials

AU - Bolhuis, M S

AU - Akkerman, O W

AU - Sturkenboom, M G G

AU - van Boven, J F M

AU - Alffenaar, J-W C

AU - Stevens, J

PY - 2023/4/1

Y1 - 2023/4/1

KW - Humans

KW - Antitubercular Agents/therapeutic use

KW - Diarylquinolines/therapeutic use

KW - Tuberculosis, Multidrug-Resistant/complications

KW - Diabetes Complications/complications

U2 - 10.5588/ijtld.22.0581

DO - 10.5588/ijtld.22.0581

M3 - Article

C2 - 37035978

SN - 1027-3719

VL - 27

SP - 335

EP - 337

JO - The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

JF - The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

IS - 4

ER -

Bolhuis MS , Akkerman OW , Sturkenboom MGG , van Boven JFM , Alffenaar JWC , Stevens J. Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2023 apr. 1;27(4):335-337. doi: 10.5588/ijtld.22.0581